NEW
YORK, Dec. 3, 2022 /PRNewswire/ -- The
intrauterine contraceptive devices (IUD) market size is forecast to
grow by USD 965.49 million from
2022 to 2027, with an accelerated CAGR of 3.98%, according to
the recent market study by Technavio. This report also offers
a 5-year historical (2017-2021) data projection of market
size, segmentation, and region.
Discover some insights on market size before buying the full
report. Request a free sample report.
Qualitative and quantitative analysis of vendors has been
conducted to help clients understand the wider business environment
as well as the strengths and weaknesses of key market players. Data
is qualitatively analyzed to categorize vendors as pure play,
category-focused, industry-focused, and diversified; it is
quantitatively analyzed to categorize vendors as dominant, leading,
strong, tentative, and weak. The Bargaining Power of Buyers
& Suppliers and the Threat of New Entrants,
Rivalry, and Substitutes have also been analyzed and rated
between LOW-HIGH to provide a holistic view of market
favorability.
Find Technavio's Exclusive Analysis of Price Sensitivity,
Adoption Lifecycle, Customer Purchase Basket, Adoption Rates, and
Purchase Criteria
- One of the core components of the customer landscape
is price sensitivity, an analysis of
which will help companies refine marketing strategies to
gain a competitive advantage.
- Another key aspect is price sensitivity
drivers (purchases are undifferentiated, the purchase
is a key cost to buyers, and quality is not
important), which range between LOW and
HIGH.
- Furthermore, market adoption rates for all regions have been
covered.
The intrauterine contraceptive devices (IUD) market report
also offers information on the criticality of inputs, R&D,
CAPEX, technology, and products of 15 vendors listed Below
–
- Bayer AG
- DKT International
- Durbin PLC
- EurimPharm Arzneimittel GmbH
- EUROGINE SL
- Gima Spa
- HLL Lifecare Ltd.
- Krishco Medical Products Pvt. Ltd.
- Laboratoire HRA Pharma SAS
- Melbea Innovations Ltd.
- Meril Life Sciences Pvt. Ltd.
- Ocon Medical Ltd.
- Pregna International Ltd
- Prosan International BV
- SMB Corp. of India
Download a sample report
Chart & Data Table on 5-Year Historic (2017-2021) Market
Size, Comparative Analysis of Segments, and Y-O-Y Growth of
intrauterine contraceptive devices (IUD) market
The market is segmented by type (hormonal
intrauterine device and copper intrauterine device) and end-user
(hospitals, gynecology clinics, and others).
- Based on type, the hormonal intrauterine
device segment became the market's largest
segment in 2022.
- Hormonal intrauterine devices decrease the risk of pelvic
inflammatory disease (PID) and tubal pregnancies and help in
treating symptoms such as polycystic ovary syndrome (PCOS) and
endometriosis.
- Hormonal intrauterine devices are more effective in preventing
pregnancies when compared with other contraception devices. They
are superior to copper intrauterine devices and pose fewer
complications and risks.
To procure the data - Buy
report!
The increasing number of unplanned pregnancies and unwanted
abortions is the key factor driving the global intrauterine
contraceptive devices (IUD) market growth.
The growing number of unplanned pregnancies is
expected to contribute to the growth of the
global intrauterine contraceptive devices (IUD) market.
Unintended pregnancies are one of the most pressing public
health problems and a significant issue in global reproductive
healthcare, imposing a substantial socioeconomic burden on society
and individuals. According to WHO, in developing countries, almost
half of the pregnancies among adolescent girls aged 15-19 years are
unplanned. The adoption of contraceptive methods can lower the rate
of such pregnancies.
Chart & Data Table on Historical Market Size (2017-2021,
Historic Industry Size & Analysis of 15 Vendors and 7
Countries
The market is segmented by region (North America, Europe, APAC, and the Rest of World). An
analysis of key leading countries has been included.
- North America, will
account for 33% of the market's growth during the forecast
period. The US leads the intrauterine contraceptive devices
(IUD) market in North
America. The presence of local market players, supportive
government initiatives, high awareness, and technological
innovations such as postpartum and reusable IUDs drive market
growth in the US.
- According to the Centers for Disease Control and Prevention
(CDC), almost half of pregnancies in the US are unintended. Hence,
the country experiences a high adoption of intrauterine devices
among women.
For Insights on the market dynamics &
segmentations, VIEW A PDF SAMPLE !
Related Reports -
Emergency Contraceptive Pills Market by Distribution Channel and
Geography – Forecast and Analysis 2021-2025: The emergency
contraceptive pills market size is forecast to grow up to
USD 75.56 million at a CAGR of 1.64%
during 2020-2025.
Female Contraceptive Market by Distribution Channel, Product,
and Geography – Forecast and Analysis 2023-2027: The female
contraceptive market is forecast to grow at a CAGR of
5.32% between 2022 and 2027. The size of the market is
forecast to increase by USD 5,.22
million.
Register for a free trial today and gain
instant access to 17,000+ market research
reports.
Technavio's SUBSCRIPTION platform
Intrauterine
Contraceptive Devices (IUD) Market Scope
|
Report
Coverage
|
Details
|
Page number
|
149
|
Base year
|
2022
|
Historic
period
|
2017-2021
|
Forecast
period
|
2023-2027
|
Growth momentum &
CAGR
|
Accelerate at a CAGR of
3.98%
|
Market growth
2023-2027
|
USD 965.49
million
|
Market
structure
|
Fragmented
|
YoY growth 2022-2023
(%)
|
3.68
|
Regional
analysis
|
North America, Europe,
APAC, and Rest of World (ROW)
|
Performing market
contribution
|
North America at
33%
|
Key
countries
|
US, China, Japan,
Germany, and France
|
Competitive
landscape
|
Leading Vendors, Market
Positioning of Vendors, Competitive Strategies, and Industry
Risks
|
Key companies
profiled
|
AbbVie Inc., Bayer AG,
DKT International, Durbin PLC, EurimPharm Arzneimittel GmbH,
EUROGINE SL, Gima Spa, HLL Lifecare Ltd., Krishco Medical Products
Pvt. Ltd., Laboratoire HRA Pharma SAS, Melbea Innovations Ltd.,
Meril Life Sciences Pvt. Ltd., Ocon Medical Ltd., Pregna
International Ltd, Prosan International BV, SMB Corp. of India,
TESPRO LLC, The Cooper Companies Inc., TRIMEDIC SUPPLY NETWORK
Ltd., and Viatris Inc.
|
Market
dynamics
|
Parent market analysis,
Market growth inducers and obstacles, Fast-growing and slow-growing
segment analysis, COVID-19 impact and recovery analysis and future
consumer dynamics, Market condition analysis for the forecast
period
|
Customization
purview
|
If our report has not
included the data that you are looking for, you can reach out to
our analysts and get segments customized.
|
Table of Contents:
1 Executive
Summary
1.1 Market Overview
Exhibit 01: Executive Summary – Chart on Market
Overview
Exhibit 02: Executive Summary – Data Table on Market
Overview
Exhibit 03: Executive Summary – Chart on Global Market
Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by
Type
Exhibit 06: Executive Summary – Chart on Market Segmentation by
End-user
Exhibit 07: Executive Summary – Chart on Incremental
Growth
Exhibit 08: Executive Summary – Data Table on Incremental
Growth
Exhibit 09: Executive Summary – Chart on Vendor Market
Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent
market
Exhibit 11: Market
Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market
definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for
2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027
($ million)
Exhibit 15: Data Table on Global - Market size and forecast
2022-2027 ($
million)
Exhibit 16: Chart on Global Market: Year-over-year growth
2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth
2022-2027
(%)
4 Historic Market Size
4.1 Global intrauterine contraceptive devices (IUD) market 2017
- 2021
Exhibit 18: Historic Market Size – Data Table on Global
intrauterine contraceptive devices (IUD) market 2017 - 2021 ($
million)
4.2 Type Segment Analysis 2017 -
2021
Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($
million)
4.3 End-User Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size – End-User Segment 2017 - 2021
($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021
($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size – Country Segment 2017 - 2021
($ million)
5 Five Forces
Analysis
5.1 Five forces
summary
Exhibit 23: Five forces analysis - Comparison between 2022 and
2027
5.2 Bargaining power of
buyers
Exhibit 24: Chart on Bargaining power of buyers – Impact of key
factors 2022 and 2027
5.3 Bargaining power of
suppliers
Exhibit 25: Bargaining power of suppliers – Impact of key
factors in 2022 and
2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants – Impact of key factors in
2022 and 2027
5.5 Threat of
substitutes
Exhibit 27: Threat of substitutes – Impact of key factors in
2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry – Impact of key factors in 2022
and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and
2027
6 Market Segmentation by
Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027
(%)
Exhibit 31: Data Table on Type - Market share 2022-2027
(%)
6.2 Comparison by
Type
Exhibit 32: Chart on Comparison by
Type
Exhibit 33: Data Table on Comparison by
Type
6.3 Hormonal intrauterine device - Market size and forecast
2022-2027
Exhibit 34: Chart on Hormonal intrauterine device - Market size
and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Hormonal intrauterine device - Market
size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Hormonal intrauterine device -
Year-over-year growth 2022-2027
(%)
Exhibit 37: Data Table on Hormonal intrauterine device -
Year-over-year growth 2022-2027
(%)
6.4 Copper intrauterine device - Market size and forecast
2022-2027
Exhibit 38: Chart on Copper intrauterine device - Market size
and forecast 2022-2027 ($
million)
Exhibit 39: Data Table on Copper intrauterine device - Market
size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Copper intrauterine device - Year-over-year
growth 2022-2027
(%)
Exhibit 41: Data Table on Copper intrauterine device -
Year-over-year growth 2022-2027
(%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($
million)
7 Market Segmentation by End-user
7.1 Market segments
Exhibit 43: Chart on End-user - Market share 2022-2027
(%)
Exhibit 44: Data Table on End-user - Market share 2022-2027
(%)
7.2 Comparison by End-user
Exhibit 45: Chart on Comparison by
End-user
Exhibit 46: Data Table on Comparison by
End-user
7.3 Hospitals - Market size and forecast
2022-2027
Exhibit 47: Chart on Hospitals - Market size and forecast
2022-2027 ($
million)
Exhibit 48: Data Table on Hospitals - Market size and forecast
2022-2027 ($ million)
Exhibit 49: Chart on Hospitals - Year-over-year growth 2022-2027
(%)
Exhibit 50: Data Table on Hospitals - Year-over-year growth
2022-2027 (%)
7.4 Gynecology clinics - Market size and forecast
2022-2027
Exhibit 51: Chart on Gynecology clinics - Market size and
forecast 2022-2027 ($
million)
Exhibit 52: Data Table on Gynecology clinics - Market size and
forecast 2022-2027 ($
million)
Exhibit 53: Chart on Gynecology clinics - Year-over-year growth
2022-2027 (%)
Exhibit 54: Data Table on Gynecology clinics - Year-over-year
growth 2022-2027
(%)
7.5 Others - Market size and forecast
2022-2027
Exhibit 55: Chart on Others - Market size and forecast 2022-2027
($
million)
Exhibit 56: Data Table on Others - Market size and forecast
2022-2027 ($
million)
Exhibit 57: Chart on Others - Year-over-year growth 2022-2027
(%)
Exhibit 58: Data Table on Others - Year-over-year growth
2022-2027
(%)
7.6 Market opportunity by End-user
Exhibit 59: Market opportunity by End-user ($ million)
8 Customer
Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer
purchase basket, adoption rates, and purchase
criteria
9 Geographic Landscape
9.1 Geographic
segmentation
Exhibit 61: Chart on Market share by geography 2022-2027
(%)
Exhibit 62: Data Table on Market share by geography 2022-2027
(%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic
comparison
Exhibit 64: Data Table on Geographic
comparison
9.3 North America - Market size
and forecast 2022-2027
Exhibit 65: Chart on North
America - Market size and forecast 2022-2027 ($
million)
Exhibit 66: Data Table on North
America - Market size and forecast 2022-2027 ($
million)
Exhibit 67: Chart on North
America - Year-over-year growth 2022-2027
(%)
Exhibit 68: Data Table on North
America - Year-over-year growth 2022-2027
(%)
9.4 Europe - Market size and
forecast
2022-2027
Exhibit 69: Chart on Europe -
Market size and forecast 2022-2027 ($
million)
Exhibit 70: Data Table on Europe - Market size and forecast 2022-2027 ($
million)
Exhibit 71: Chart on Europe -
Year-over-year growth 2022-2027
(%)
Exhibit 72: Data Table on Europe - Year-over-year growth 2022-2027
(%)
9.5 APAC - Market size and forecast
2022-2027
Exhibit 73: Chart on APAC - Market size and forecast 2022-2027
($
million)
Exhibit 74: Data Table on APAC - Market size and forecast
2022-2027 ($
million)
Exhibit 75: Chart on APAC - Year-over-year growth 2022-2027
(%)
Exhibit 76: Data Table on APAC - Year-over-year growth 2022-2027
(%)
9.6 Rest of World (ROW) - Market size and forecast
2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and
forecast 2022-2027 ($
million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and
forecast 2022-2027 ($
million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth
2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year
growth 2022-2027
(%)
9.7 US - Market size and forecast
2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($
million)
Exhibit 82: Data Table on US - Market size and forecast
2022-2027 ($
million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027
(%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027
(%)
9.8 Germany - Market size and
forecast 2022-2027
Exhibit 85: Chart on Germany -
Market size and forecast 2022-2027 ($
million)
Exhibit 86: Data Table on Germany - Market size and forecast 2022-2027
($ million)
Exhibit 87: Chart on Germany -
Year-over-year growth 2022-2027
(%)
Exhibit 88: Data Table on Germany - Year-over-year growth 2022-2027
(%)
9.9 China - Market size and
forecast 2022-2027
Exhibit 89: Chart on China -
Market size and forecast 2022-2027 ($
million)
Exhibit 90: Data Table on China
- Market size and forecast 2022-2027 ($
million)
Exhibit 91: Chart on China -
Year-over-year growth 2022-2027
(%)
105
Exhibit 92: Data Table on China
- Year-over-year growth 2022-2027
(%)
9.10 France - Market size and
forecast
2022-2027
Exhibit 93: Chart on France -
Market size and forecast 2022-2027 ($
million)
Exhibit 94: Data Table on France - Market size and forecast 2022-2027 ($
million)
Exhibit 95: Chart on France -
Year-over-year growth 2022-2027
(%)
Exhibit 96: Data Table on France - Year-over-year growth 2022-2027
(%)
9.11 Japan - Market size and
forecast
2022-2027
Exhibit 97: Chart on Japan -
Market size and forecast 2022-2027 ($
million)
Exhibit 98: Data Table on Japan
- Market size and forecast 2022-2027 ($
million)
Exhibit 99: Chart on Japan -
Year-over-year growth 2022-2027
(%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027
(%)
9.12 Market opportunity by
geography
Exhibit 101: Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market
challenges
10.3 Impact of drivers and
challenges
Exhibit 102: Impact of drivers and challenges in 2022 and
2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor
landscape
Exhibit 103: Overview on Criticality of inputs and Factors of
differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of
disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and
classification
12.3 AbbVie
Inc.
Exhibit 108: AbbVie Inc. - Overview
Exhibit 109: AbbVie Inc. - Product / Service
Exhibit 110: AbbVie Inc. - Key
offerings
12.4 Bayer
AG
Exhibit 111: Bayer AG - Overview
Exhibit 112: Bayer AG - Business segments
Exhibit 113: Bayer AG - Key
offerings
Exhibit 114: Bayer AG - Segment
focus
12.5 DKT
International
Exhibit 115: DKT International -
Overview
Exhibit 116: DKT International - Product /
Service
Exhibit 117: DKT International - Key
offerings
12.6 EUROGINE SL
Exhibit 118: EUROGINE SL -
Overview
Exhibit 119: EUROGINE SL - Product /
Service
Exhibit 120: EUROGINE SL - Key offerings
12.7 HLL Lifecare
Ltd.
Exhibit 121: HLL Lifecare Ltd. -
Overview
Exhibit 122: HLL Lifecare Ltd. - Product /
Service
Exhibit 123: HLL Lifecare Ltd. - Key
offerings
12.8 Krishco Medical Products Pvt.
Ltd.
Exhibit 124: Krishco Medical Products Pvt. Ltd. -
Overview
Exhibit 125: Krishco Medical Products Pvt. Ltd. - Product /
Service
Exhibit 126: Krishco Medical Products Pvt. Ltd. - Key
offerings
12.9 Laboratoire HRA Pharma SAS
Exhibit 127: Laboratoire HRA Pharma SAS -
Overview
Exhibit 128: Laboratoire HRA Pharma SAS - Product /
Service
Exhibit 129: Laboratoire HRA Pharma SAS - Key
offerings
12.10 Melbea Innovations
Ltd.
Exhibit 130: Melbea Innovations Ltd. -
Overview
Exhibit 131: Melbea Innovations Ltd. - Product /
Service
Exhibit 132: Melbea Innovations Ltd. - Key
offerings
12.11 Ocon Medical
Ltd.
Exhibit 133: Ocon Medical Ltd. - Overview
Exhibit 134: Ocon Medical Ltd. - Product /
Service
Exhibit 135: Ocon Medical Ltd. - Key
offerings
12.12 Pregna International
Ltd
Exhibit 136: Pregna International Ltd -
Overview
Exhibit 137: Pregna International Ltd - Product /
Service
Exhibit 138: Pregna International Ltd - Key
offerings
12.13 Prosan International
BV
Exhibit 139: Prosan International BV -
Overview
Exhibit 140: Prosan International BV - Product /
Service
Exhibit 141: Prosan International BV - Key
offerings
12.14 SMB Corp. of India
Exhibit: SMB Corp. of India -
Overview
Exhibit 142: SMB Corp. of India
- Product /
Service
Exhibit 143: SMB Corp. of India
- Key
offerings
12.15 TESPRO LLC
Exhibit 144: TESPRO LLC -
Overview
Exhibit 145: TESPRO LLC - Product /
Service
Exhibit 146: TESPRO LLC - Key
offerings
12.16 The Cooper Companies Inc.
Exhibit 147 : The Cooper Companies Inc. -
Overview
Exhibit 148: The Cooper Companies Inc. - Business
segments
Exhibit 149: The Cooper Companies Inc. - Key
offerings
Exhibit 150: The Cooper Companies Inc. - Segment
focus
12.17 TRIMEDIC SUPPLY NETWORK Ltd.
Exhibit 151: TRIMEDIC SUPPLY NETWORK Ltd. -
Overview
Exhibit 152: TRIMEDIC SUPPLY NETWORK Ltd. - Product /
Service
Exhibit 153: TRIMEDIC SUPPLY NETWORK Ltd. - Key offerings
13 Appendix
13.1 Scope of the
report
13.2 Inclusions and exclusions
checklist
Exhibit 154: Inclusions
checklist
Exhibit 155 : Exclusions
checklist
13.3 Currency conversion rates for
US$
Exhibit 157: Currency conversion rates for
US$
13.4 Research methodology
Exhibit 158: Research methodology
Exhibit 159: Validation techniques employed for market
sizing
Exhibit 160: Information
sources
13.5 List of
abbreviations
Exhibit 161: List of
abbreviations
About Us
Technavio is a leading global technology research and advisory
company. Their research and analysis focus on emerging market
trends and provide actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions. With over 500 specialized analysts,
Technavio's report library consists of more than 17,000 reports and
counting, covering 800 technologies, spanning 50 countries. Their
client base consists of enterprises of all sizes, including more
than 100 Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/intrauterine-contraceptive-devices-iud-market-2023-2027-5-year-2017-2021-historic-industry-size--analysis-of-15-vendors-and-7-countries---technavio-301691360.html
SOURCE Technavio